Combined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCC
10.1002/hep.20613
Saved in:
Main Authors: | Graepler, F., Verbeek, B., Graeter, T., Smirnow, I., Gregor, M., Lauer, U.M., Kong, H.L., Schuppan, D., Bauer, M., Vonthein, R. |
---|---|
其他作者: | MEDICINE |
格式: | Article |
出版: |
2014
|
在線閱讀: | http://scholarbank.nus.edu.sg/handle/10635/117595 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
機構: | National University of Singapore |
相似書籍
-
Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease
由: Fuanglada Tongprasert, et al.
出版: (2018) -
Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease
由: Tongprasert F., et al.
出版: (2014) -
Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease
由: Fuanglada Tongprasert, et al.
出版: (2018) -
Semaphorin-PlexinD1 Signaling Limits Angiogenic Potential via the VEGF Decoy Receptor sFlt1
由: Zygmunt, Tomasz, et al.
出版: (2021) -
Pharmacokinetics of recombinant human endostatin in rats
由: Yang, X.-X., et al.
出版: (2014)